Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale
2020 · Particle and Fibre Toxicology · 237 citations
https://doi.org/10.1186/s12989-020-00344-4
S
Sabina Halappanavar
Health Canada(CA)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
144
Papers
5.2K
Citations
47
h-index
87
i10-index
Sabina Halappanavar is an academic researcher from Health Canada. The author has contributed to research in topics: Nanoparticles: synthesis and applications & Air Quality and Health Impacts & Carcinogens and Genotoxicity Assessment. The author has an h-index of 47, co-authored 123 publications.
ORCID: 0000-0001-6283-237XPapers by this author
worksNano-risk Science: application of toxicogenomics in an adverse outcome pathway framework for risk assessment of multi-walled carbon nanotubes
2015 · Particle and Fibre Toxicology · 135 citations
https://doi.org/10.1186/s12989-016-0125-9
Meta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterials
2015 · Particle and Fibre Toxicology · 85 citations
https://doi.org/10.1186/s12989-016-0137-5
Changes in cholesterol homeostasis and acute phase response link pulmonary exposure to multi-walled carbon nanotubes to risk of cardiovascular disease
2015 · Toxicology and Applied Pharmacology · 67 citations
https://doi.org/10.1016/j.taap.2015.01.011
Stat-6 signaling pathway and not Interleukin-1 mediates multi-walled carbon nanotube-induced lung fibrosis in mice: insights from an adverse outcome pathway framework
2017 · Particle and Fibre Toxicology · 49 citations
https://doi.org/10.1186/s12989-017-0218-0
Comparative transcriptomic analyses to scrutinize the assumption that genotoxic PAHs exert effects via a common mode of action
2015 · Archives of Toxicology · 34 citations
https://doi.org/10.1007/s00204-015-1595-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat